Annual CFI
-$2000.00
+$256.00 K+99.22%
31 March 2024
Summary:
Sonoma Pharmaceuticals annual cash flow from investing activities is currently -$2000.00, with the most recent change of +$256.00 thousand (+99.22%) on 31 March 2024. During the last 3 years, it has fallen by -$390.00 thousand (-100.52%). SNOA annual CFI is now -100.01% below its all-time high of $18.22 million, reached on 31 March 2017.SNOA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$26.00 K
-$21.00 K-420.00%
30 September 2024
Summary:
Sonoma Pharmaceuticals quarterly cash flow from investing activities is currently -$26.00 thousand, with the most recent change of -$21.00 thousand (-420.00%) on 30 September 2024. Over the past year, it has dropped by -$25.00 thousand (-2500.00%). SNOA quarterly CFI is now -100.15% below its all-time high of $17.29 million, reached on 31 December 2016.SNOA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$14.00 K
-$24.00 K-240.00%
30 September 2024
Summary:
Sonoma Pharmaceuticals TTM cash flow from investing activities is currently -$14.00 thousand, with the most recent change of -$24.00 thousand (-240.00%) on 30 September 2024. Over the past year, it has increased by +$88.00 thousand (+86.27%). SNOA TTM CFI is now -100.08% below its all-time high of $18.22 million, reached on 31 March 2017.SNOA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SNOA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +99.2% | -2500.0% | +86.3% |
| 3 y3 years | -100.5% | -100.0% | +66.7% |
| 5 y5 years | +98.5% | -178.8% | +68.2% |
SNOA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.5% | +99.2% | -176.5% | +86.1% | -240.0% | +94.8% |
| 5 y | 5 years | -100.0% | +99.2% | -100.7% | +86.1% | -100.3% | +94.8% |
| alltime | all time | -100.0% | +99.9% | -100.2% | +87.2% | -100.1% | +97.9% |
Sonoma Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$26.00 K(+420.0%) | -$14.00 K(-240.0%) |
| June 2024 | - | -$5000.00(-127.8%) | $10.00 K(-600.0%) |
| Mar 2024 | -$2000.00(-99.2%) | $18.00 K(-1900.0%) | -$2000.00(-98.0%) |
| Dec 2023 | - | -$1000.00(-50.0%) | -$102.00 K(+52.2%) |
| Sept 2023 | - | -$2000.00(-88.2%) | -$67.00 K(-73.4%) |
| June 2023 | - | -$17.00 K(-79.3%) | -$252.00 K(-2.3%) |
| Mar 2023 | -$258.00 K(+160.6%) | -$82.00 K(-341.2%) | -$258.00 K(+8.9%) |
| Dec 2022 | - | $34.00 K(-118.2%) | -$237.00 K(-12.5%) |
| Sept 2022 | - | -$187.00 K(+713.0%) | -$271.00 K(+271.2%) |
| June 2022 | - | -$23.00 K(-62.3%) | -$73.00 K(-26.3%) |
| Mar 2022 | -$99.00 K(-125.5%) | -$61.00 K(<-9900.0%) | -$99.00 K(+135.7%) |
| Dec 2021 | - | $0.00(-100.0%) | -$42.00 K(-66.4%) |
| Sept 2021 | - | $11.00 K(-122.4%) | -$125.00 K(-41.9%) |
| June 2021 | - | -$49.00 K(+1125.0%) | -$215.00 K(-155.4%) |
| Mar 2021 | $388.00 K(-89.4%) | -$4000.00(-95.2%) | $388.00 K(-90.5%) |
| Dec 2020 | - | -$83.00 K(+5.1%) | $4.07 M(-2.8%) |
| Sept 2020 | - | -$79.00 K(-114.3%) | $4.19 M(-0.5%) |
| June 2020 | - | $554.00 K(-84.9%) | $4.21 M(+15.5%) |
| Mar 2020 | $3.64 M(-2881.7%) | $3.68 M(>+9900.0%) | $3.64 M(-8381.8%) |
| Dec 2019 | - | $33.00 K(-157.9%) | -$44.00 K(-58.1%) |
| Sept 2019 | - | -$57.00 K(+375.0%) | -$105.00 K(-18.0%) |
| June 2019 | - | -$12.00 K(+50.0%) | -$128.00 K(-2.3%) |
| Mar 2019 | -$131.00 K(-34.8%) | -$8000.00(-71.4%) | -$131.00 K(0.0%) |
| Dec 2018 | - | -$28.00 K(-65.0%) | -$131.00 K(+9.2%) |
| Sept 2018 | - | -$80.00 K(+433.3%) | -$120.00 K(+166.7%) |
| June 2018 | - | -$15.00 K(+87.5%) | -$45.00 K(-77.6%) |
| Mar 2018 | -$201.00 K(-101.1%) | -$8000.00(-52.9%) | -$201.00 K(-125.2%) |
| Dec 2017 | - | -$17.00 K(+240.0%) | $799.00 K(-95.6%) |
| Sept 2017 | - | -$5000.00(-97.1%) | $18.11 M(+0.2%) |
| June 2017 | - | -$171.00 K(-117.2%) | $18.06 M(-0.9%) |
| Mar 2017 | $18.22 M(+334.8%) | $992.00 K(-94.3%) | $18.22 M(+5.7%) |
| Dec 2016 | - | $17.29 M(<-9900.0%) | $17.24 M(<-9900.0%) |
| Sept 2016 | - | -$48.00 K(+336.4%) | -$168.00 K(-15.2%) |
| June 2016 | - | -$11.00 K(-200.0%) | -$198.00 K(-104.7%) |
| Mar 2016 | $4.19 M | $11.00 K(-109.2%) | $4.19 M(-17.7%) |
| Dec 2015 | - | -$120.00 K(+53.8%) | $5.09 M(-1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2015 | - | -$78.00 K(-101.8%) | $5.15 M(-2.1%) |
| June 2015 | - | $4.38 M(+378.5%) | $5.26 M(+501.3%) |
| Mar 2015 | $875.00 K(-296.6%) | $915.00 K(-1552.4%) | $875.00 K(-1635.1%) |
| Dec 2014 | - | -$63.00 K(-303.2%) | -$57.00 K(-48.2%) |
| Sept 2014 | - | $31.00 K(-487.5%) | -$110.00 K(-61.1%) |
| June 2014 | - | -$8000.00(-52.9%) | -$283.00 K(-36.4%) |
| Mar 2014 | -$445.00 K(+20.3%) | -$17.00 K(-85.3%) | -$445.00 K(-18.2%) |
| Dec 2013 | - | -$116.00 K(-18.3%) | -$544.00 K(+14.0%) |
| Sept 2013 | - | -$142.00 K(-16.5%) | -$477.00 K(-5.9%) |
| June 2013 | - | -$170.00 K(+46.6%) | -$507.00 K(+37.0%) |
| Mar 2013 | -$370.00 K(+2.8%) | -$116.00 K(+136.7%) | -$370.00 K(-4.9%) |
| Dec 2012 | - | -$49.00 K(-71.5%) | -$389.00 K(-0.5%) |
| Sept 2012 | - | -$172.00 K(+421.2%) | -$391.00 K(+24.1%) |
| June 2012 | - | -$33.00 K(-75.6%) | -$315.00 K(-12.5%) |
| Mar 2012 | -$360.00 K(+119.5%) | -$135.00 K(+164.7%) | -$360.00 K(+10.4%) |
| Dec 2011 | - | -$51.00 K(-46.9%) | -$326.00 K(+14.4%) |
| Sept 2011 | - | -$96.00 K(+23.1%) | -$285.00 K(+33.2%) |
| June 2011 | - | -$78.00 K(-22.8%) | -$214.00 K(+30.5%) |
| Mar 2011 | -$164.00 K(-10.9%) | -$101.00 K(+910.0%) | -$164.00 K(+30.2%) |
| Dec 2010 | - | -$10.00 K(-60.0%) | -$126.00 K(-7.4%) |
| Sept 2010 | - | -$25.00 K(-10.7%) | -$136.00 K(-20.5%) |
| June 2010 | - | -$28.00 K(-55.6%) | -$171.00 K(-7.1%) |
| Mar 2010 | -$184.00 K(-56.6%) | -$63.00 K(+215.0%) | -$184.00 K(-16.4%) |
| Dec 2009 | - | -$20.00 K(-66.7%) | -$220.00 K(-19.1%) |
| Sept 2009 | - | -$60.00 K(+46.3%) | -$272.00 K(-11.1%) |
| June 2009 | - | -$41.00 K(-58.6%) | -$306.00 K(-27.8%) |
| Mar 2009 | -$424.00 K(-31.3%) | -$99.00 K(+37.5%) | -$424.00 K(-19.7%) |
| Dec 2008 | - | -$72.00 K(-23.4%) | -$528.00 K(-15.2%) |
| Sept 2008 | - | -$94.00 K(-40.9%) | -$623.00 K(-6.7%) |
| June 2008 | - | -$159.00 K(-21.7%) | -$668.00 K(+8.3%) |
| Mar 2008 | -$617.00 K(-29.6%) | -$203.00 K(+21.6%) | -$617.00 K(+49.0%) |
| Dec 2007 | - | -$167.00 K(+20.1%) | -$414.00 K(+67.6%) |
| Sept 2007 | - | -$139.00 K(+28.7%) | -$247.00 K(+128.7%) |
| June 2007 | - | -$108.00 K | -$108.00 K |
| Mar 2007 | -$877.00 K(-44.6%) | - | - |
| Mar 2006 | -$1.58 M(+41.5%) | - | - |
| Mar 2005 | -$1.12 M | - | - |
FAQ
- What is Sonoma Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals annual CFI year-on-year change?
- What is Sonoma Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals quarterly CFI year-on-year change?
- What is Sonoma Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals TTM CFI year-on-year change?
What is Sonoma Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of SNOA is -$2000.00
What is the all time high annual CFI for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high annual cash flow from investing activities is $18.22 M
What is Sonoma Pharmaceuticals annual CFI year-on-year change?
Over the past year, SNOA annual cash flow from investing activities has changed by +$256.00 K (+99.22%)
What is Sonoma Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of SNOA is -$26.00 K
What is the all time high quarterly CFI for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high quarterly cash flow from investing activities is $17.29 M
What is Sonoma Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, SNOA quarterly cash flow from investing activities has changed by -$25.00 K (-2500.00%)
What is Sonoma Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of SNOA is -$14.00 K
What is the all time high TTM CFI for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high TTM cash flow from investing activities is $18.22 M
What is Sonoma Pharmaceuticals TTM CFI year-on-year change?
Over the past year, SNOA TTM cash flow from investing activities has changed by +$88.00 K (+86.27%)